Philadelphia-based SFA Therapeutics has a big vision. The company, CEO and co-founder Ira Spector, Ph.D., tells BioBuzz, “wants to change the way medicine is practiced in the treatment of autoimmune disease.” Spector notes that the current standard-of-care approach to autoimmune diseases is immunosuppression, “to dumb down the symptoms,” which he says is like “treating a headache with a […]

Several vaccine companies say they are expecting breakthroughs as early as this year as they pursue new ways to protect people against SARS-CoV-2, the virus that causes COVID-19. The Food and Drug Administration is set to convene a panel of its outside vaccine advisers later this month to weigh key issues over the future of COVID-19 vaccines, including […]

While biopharma giants showed mixed results in 2022 trying to treat breast cancer with selective ER degraders (SERDs), a much smaller drug developer is preparing to test a two-prong approach to beating the disease in a pivotal trial. Olema Oncology plans in mid-year to launch a Phase III study for its lead candidate OP-1250 that […]